Chlamydia screening among young women: individual- and provider-level differences in testing
- PMID: 21262889
- PMCID: PMC3025420
- DOI: 10.1542/peds.2010-0967
Chlamydia screening among young women: individual- and provider-level differences in testing
Abstract
Objective: We assessed differences in chlamydia screening rates according to race/ethnicity, insurance status, age, and previous sexually transmitted infection (STI) or pregnancy.
Methods: A retrospective cohort study was performed using electronic medical record and billing data for women 14 to 25 years of age in 2002-2007, assessing differences in the odds of a chlamydia test being performed at that visit.
Results: Adjusted odds of a chlamydia test being performed were lower among women 14 to 15 years of age (odds ratio: 0.83 [95% confidence interval: 0.70-1.00]) and 20 to 25 years of age (20-21 years, odds ratio: 0.78 [95% confidence interval: 0.70-0.89]; 22-23 years, odds ratio: 0.76 [95% confidence interval: 0.67-0.87]; 24-25 years, odds ratio: 0.64 [95% confidence interval: 0.57-0.73]), compared with women 18 to 19 years of age. Black women had 3 times increased odds (odds ratio: 2.96 [95% confidence interval: 2.66-3.28]) and Hispanic women nearly 13 times increased odds (odds ratio: 12.89 [95% confidence interval: 10.85-15.30]) of testing, compared with white women. Women with public (odds ratio: 1.74 [95% confidence interval: 1.58-1.91]) and public pending (odds ratio: 6.85 [95% confidence interval: 5.13-9.15]) insurance had increased odds of testing, compared with women with private insurance. After first STI diagnosis, differences according to race/ethnicity persisted but were smaller; after first pregnancy, differences persisted.
Conclusions: Despite recommendations to screen all sexually active young women for chlamydia, providers screened women differently according to age, race/ethnicity, and insurance status, although differences were reduced after first STI or pregnancy.
Comment in
-
Higher rates of Chlamydia infection in low-income minority women may reflect differences in provider screening practices.J Midwifery Womens Health. 2011 May-Jun;56(3):314-5. doi: 10.1111/j.1542-2011.2011.00065_2.x. J Midwifery Womens Health. 2011. PMID: 21535380 No abstract available.
Similar articles
-
Disparities in chlamydia testing among young women with sexually transmitted infection symptoms.Sex Transm Dis. 2010 Dec;37(12):751-5. doi: 10.1097/OLQ.0b013e3181e50044. Sex Transm Dis. 2010. PMID: 20644496
-
Sexually transmissible infection testing among pregnant women in the US, 2011-15.Sex Health. 2020 Feb;17(1):1-8. doi: 10.1071/SH19002. Sex Health. 2020. PMID: 31677644 Free PMC article.
-
Over-screening for chlamydia and gonorrhea among urban women age ≥25 years.Am J Obstet Gynecol. 2015 Jan;212(1):40.e1-6. doi: 10.1016/j.ajog.2014.06.051. Epub 2014 Jun 28. Am J Obstet Gynecol. 2015. PMID: 24983680
-
Sexually transmitted infections in pregnancy.Nurs Womens Health. 2014 Feb-Mar;18(1):67-72. doi: 10.1111/1751-486X.12095. Nurs Womens Health. 2014. PMID: 24548498 Review.
-
Developments in the screening for Chlamydia trachomatis: a review.Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. doi: 10.1016/s0889-8545(03)00076-7. Obstet Gynecol Clin North Am. 2003. PMID: 14719842 Review.
Cited by
-
Sexually transmitted infection testing and diagnosis in adolescents and young adults with sickle cell disease.Pediatr Blood Cancer. 2024 Oct;71(10):e31240. doi: 10.1002/pbc.31240. Epub 2024 Aug 4. Pediatr Blood Cancer. 2024. PMID: 39099153
-
A retrospective review of the rate of sexually transmitted infections in adolescents after universal screening protocol implementation in an urban United States clinic.Prev Med Rep. 2024 Feb 29;40:102672. doi: 10.1016/j.pmedr.2024.102672. eCollection 2024 Apr. Prev Med Rep. 2024. PMID: 38464418 Free PMC article.
-
Racial and Ethnic Differences in Chlamydia and Gonorrhea Testing Locations Among Medicaid-Insured Youth.J Adolesc Health. 2024 Feb;74(2):381-384. doi: 10.1016/j.jadohealth.2023.08.032. Epub 2023 Oct 8. J Adolesc Health. 2024. PMID: 37804298
-
Adherence to Sexually Transmitted Infection Screening in Pregnancy.J Womens Health (Larchmt). 2023 Jun;32(6):652-656. doi: 10.1089/jwh.2022.0409. Epub 2023 Apr 20. J Womens Health (Larchmt). 2023. PMID: 37083421 Free PMC article.
-
Growing Evidence Supports an Implementation Shift Toward Vaginal Sampling for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Screening.Ann Fam Med. 2023 Mar-Apr;21(2):100-102. doi: 10.1370/afm.2959. Ann Fam Med. 2023. PMID: 36973048 Free PMC article. No abstract available.
References
-
- Centers for Disease Control and Prevention Sexually Transmitted Diseases Surveillance, 2007. Atlanta, GA: U.S. Department of Health and Human Services; December, 2008. Available at: http://www.cdc.gov/std/stats07/minorities.htm
-
- Institute of Medicine, Committee on Prevention and Control of Sexually Transmitted Diseases The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press; 1997
-
- Weinstock H, Berman S, Cates W., Jr Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6–10 - PubMed
-
- McClure JB, Scholes D, Grothaus L, et al. Chlamydia screening in at-risk adolescent females: an evaluation of screening practices and modifiable screening correlates. J Adolesc Health. 2006;38(6):726–733 - PubMed
-
- Meyers D, Wolff T, Gregory K, et al. USPSTF recommendations for STI screening. Am Fam Physician. 2008;77(6):819–824 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
